4
Changes in Ownership
CNS Pharmaceuticals, Inc. Filed Acc 0001683168-24-002284
Options or other derivatives
- Chief Executive Officer acquired 166,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Climaco John M · Chief Executive Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-04-08 | Grant or award : show line 1 in the form Option to purchase common stock | +83,000 | 476,533 | D |
| 2024-04-08 | Grant or award : show line 2 in the form Restricted Stock Units | +83,000 | 559,533 | D |
Loading xslF345X05/ownership.xml…